An innovative medicines company dedicated to reimagining medicine to improve and extend people's lives.
Key features:
Innovative therapies for serious diseasesResearch and development leadershipGlobal reach with medicines available in multiple countriesFocus on high unmet patient needsAdvanced technology platforms for drug development
A pioneering pharmaceutical manufacturer focused on lifesaving injectable drugs.
Key features:
Innovative manufacturing processesSpecialty drug developmentFocus on critical-need medicationsStreamlined drug usabilityFirst-to-market FDA-approved drugs
Comanche Biopharma is dedicated to making pregnancies safer through innovative therapies.
Key features:
Development of investigational siRNA medicineFocus on preterm preeclampsiaCommitment to evidence-based therapiesAccessibility for all women and babiesSupport resources for patients and survivors
QED Therapeutics is dedicated to developing treatment options for skeletal dysplasias.
Key features:
Breakthrough therapy designation by the FDAClinical trials for achondroplasia and hypochondroplasiaResearch and development in skeletal dysplasias
Pioneering AI-driven drug discovery.
Key features:
AI-driven drug discoveryComputational methods for drug developmentData set creationEnhanced certainty in drug discoveryNovel therapeutic creation
ANI Pharmaceuticals is a diversified bio-pharmaceutical company focused on developing and marketing prescription pharmaceutical products.
Key features:
FDA-approved productsBranded medicationsGeneric medicationsPatient-focused solutionsDiverse therapeutic areas
Transforming science to improve patient lives through targeted medicines.
Key features:
Targeted therapies developmentClinical trial advancementPrecision medicine focusExpertise in biologyWorld-class medicinal chemistry
Dedicated to improving health through innovative treatments and technologies.
Key features:
Innovative drug discoveryAccelerated drug developmentDiverse therapeutic pipelineFocus on unmet medical needsCommitment to patient experience
Rezolute is focused on developing therapies for rare diseases, particularly hyperinsulinism.
Key features:
Development of novel therapiesFocus on congenital hyperinsulinismFocus on tumor hyperinsulinismPhase 3 clinical trialsExpanded Access Program
Innovative solutions for retinal disease treatment.
Key features:
Innovative drug developmentClinical trial design expertiseFocus on reducing treatment burdenLong-term vision preservationTargeting multiple retinal diseases
Heron Therapeutics develops innovative therapies for acute care and oncology patients.
Key features:
FDA approved therapies for chemotherapy-induced nausea and vomitingSubcutaneous injection for CINV preventionIntravenous infusion options for CINVPostoperative pain management solutionsRapid IV injection for postoperative nausea and vomiting
Olema Oncology is dedicated to developing innovative cancer medicines.
Key features:
Development of innovative cancer treatmentsFocus on patient care in breast cancerExpert leadership team in oncologyCommitment to safety and effectiveness of treatmentsResearch on metastatic disease
Amylyx Pharmaceuticals is dedicated to developing novel therapies for diseases with high unmet needs.
Key features:
Rigorous scientific researchPipeline of investigational therapiesFocus on diseases with high unmet needsCommunity engagementCommitment to urgency in treatment development
A global pharmaceutical company focused on innovative treatments for cardiovascular disease.
Key features:
Innovative therapeutic developmentFocus on cardiovascular disease managementGlobal impact on patient health
Cyteir is a clinical-stage oncology company focused on cancer treatment.
Key features:
Oral investigational drugInhibits monocarboxylate transportersCombination therapy with capecitabineCombination therapy with gemcitabinePhase 1/2 clinical study